Observational study / 2010
Abnormal intestinal permeability was more frequent in patients with autism and their relatives, and was lower in those on a gluten-casein-free diet.
Intestinal permeability (IPT) via lactulose/mannitol test and faecal calprotectin (FC) were evaluated in patients with autism, their first-degree relatives, and controls. Abnormal IPT was observed in 36.7% of patients with autism and 21.2% of relatives, compared to 4.8% of normal subjects. Patients with autism on a reported gluten-casein-free diet showed significantly lower IPT values than those on an unrestricted diet and controls. FC was elevated in 24.4% of autistic patients and 11.6% of relatives, but did not correlate with abnormal IPT.
Shows an association, not proof of cause and effect.
- Study type
- Case-control study
- Who was studied
- Patients with autism, their first-degree relatives, and adult and child controls
- What was measured
- Intestinal permeability (lactulose/mannitol test) and faecal calprotectin
THE PAPER
Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives.
de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. J Pediatr Gastroenterol Nutr, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.